SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001718108-23-000003
Filing Date
2023-03-09
Accepted
2023-03-09 07:01:05
Documents
14
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K surf-20230309.htm   iXBRL 8-K 37609
2 EX-99.1` surf-392023xex991.htm EX-99.1` 58814
6 logo.gif GRAPHIC 12839
  Complete submission text file 0001718108-23-000003.txt   269896

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20230309.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20230309_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20230309_pre.xml EX-101.PRE 13595
8 EXTRACTED XBRL INSTANCE DOCUMENT surf-20230309_htm.xml XML 12799
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38459 | Film No.: 23718135
SIC: 2836 Biological Products, (No Diagnostic Substances)